Popular Statins Go Head To Head In New, Global Cholesterol Trial
A new trial at the Methodist DeBakey Heart Center will provide a head to head competition between two popular statin therapies to see which does a better job at lowering the levels of bad cholesterol (LDL-C) in patients’ blood. “High cholesterol leads to heart disease and stroke, two of our nation’s top killers,” said Dr.
